Abstract
Stable and orally bio-available pro-drugs of CPS11 were synthesized. They are active on human umbilical vein endothelial cell proliferation assay and tube formation assay. The therapeutic efficacy and safety of 4 as a single agent or combined with Taxol in the treatment of MX-1 human breast cancer xenograft were evaluated. Compound 4 as a single agent failed to produce an anti-tumor activity, while it significantly enhanced antitumor potency of Taxol.
Copyright © 2011 Elsevier Ltd. All rights reserved.
MeSH terms
-
Biological Availability
-
Cell Proliferation / drug effects
-
Cells, Cultured
-
Chromatography, High Pressure Liquid
-
Drug Screening Assays, Antitumor
-
Drug Stability
-
Endothelium, Vascular / cytology
-
Endothelium, Vascular / drug effects
-
Female
-
Humans
-
Prodrugs / pharmacokinetics*
-
Thalidomide / analogs & derivatives*
-
Thalidomide / pharmacokinetics
-
Thalidomide / pharmacology
-
Umbilical Veins / cytology
-
Umbilical Veins / drug effects
-
Xenograft Model Antitumor Assays
Substances
-
CPS 11
-
Prodrugs
-
Thalidomide